D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 71 Citations 20,423 210 World Ranking 526 National Ranking 11
Medicine D-index 90 Citations 28,989 354 World Ranking 5996 National Ranking 80

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

His primary areas of investigation include Immunology, Internal medicine, Acquired immunodeficiency syndrome, Cohort study and Viral load. His Immunology research incorporates elements of Odds ratio, Incidence and Hazard ratio. His Internal medicine research incorporates themes from Gastroenterology, Surgery and Ritonavir.

His studies in Acquired immunodeficiency syndrome integrate themes in fields like Viral disease, Pharmacotherapy and Epidemiology. His Cohort study study combines topics in areas such as Prospective cohort study, Survival analysis, Pediatrics and Cohort. Hansjakob Furrer combines subjects such as Developed country, Environmental health, Cellular immunity, Program evaluation and Antiretroviral therapy with his study of Viral load.

His most cited work include:

  • Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study (1019 citations)
  • Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study (857 citations)
  • Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study. (804 citations)

What are the main themes of his work throughout his whole career to date?

Hansjakob Furrer mostly deals with Internal medicine, Immunology, Cohort study, Acquired immunodeficiency syndrome and Viral load. His Internal medicine study frequently draws connections between adjacent fields such as Surgery. His research in Immunology intersects with topics in Tuberculosis and Virology.

His study focuses on the intersection of Cohort study and fields such as Odds ratio with connections in the field of Logistic regression. The study incorporates disciplines such as Pharmacotherapy and Risk factor in addition to Acquired immunodeficiency syndrome. His study in Viral load is interdisciplinary in nature, drawing from both Gastroenterology and Regimen.

He most often published in these fields:

  • Internal medicine (47.48%)
  • Immunology (37.65%)
  • Cohort study (32.37%)

What were the highlights of his more recent work (between 2016-2021)?

  • Internal medicine (47.48%)
  • Cohort study (32.37%)
  • Prospective cohort study (11.03%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Cohort study, Prospective cohort study, Viral load and Odds ratio. Within one scientific family, Hansjakob Furrer focuses on topics pertaining to Randomized controlled trial under Cohort study, and may sometimes address concerns connected to Emergency medicine, Linear model and Marginal structural model. His work deals with themes such as Regimen, Acquired immunodeficiency syndrome, Coinfection, Seroconversion and Pediatrics, which intersect with Prospective cohort study.

His Viral load study necessitates a more in-depth grasp of Immunology. Particularly relevant to T lymphocyte is his body of work in Immunology. His Odds ratio research is multidisciplinary, incorporating elements of Overweight, Men who have sex with men and Quartile, Confidence interval.

Between 2016 and 2021, his most popular works were:

  • Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study (249 citations)
  • Adverse events of raltegravir and dolutegravir (53 citations)
  • Hepatitis Delta-Associated Mortality in HIV/HBV-coinfected Patients (45 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Acquired immunodeficiency syndrome
  • Virus

Hansjakob Furrer mainly focuses on Prospective cohort study, Internal medicine, Cohort study, Cohort and Pediatrics. His Prospective cohort study research integrates issues from Acquired immunodeficiency syndrome, Viral load and Hazard ratio. His Internal medicine study incorporates themes from Virological response, Surgery, Immunology and Hepatitis C virus.

Hansjakob Furrer interconnects Liver cancer and Hepatocellular carcinoma in the investigation of issues within Immunology. His Cohort study study integrates concerns from other disciplines, such as Dolutegravir, Discontinuation and Confidence interval. The Pediatrics study combines topics in areas such as Odds ratio, Relative risk, Randomized controlled trial, Reverse-transcriptase inhibitor and Drug resistance.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study

Andri Rauch;Zoltán Kutalik;Zoltán Kutalik;Patrick Descombes;Tao Cai.
Gastroenterology (2010)

1400 Citations

Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study.

Gilbert Greub;Bruno Ledergerber;M. Battegay;P. Grob.
The Lancet (2000)

1209 Citations

Clinical progression and virological failure on highly active antiretroviral therapy in HIV-1 patients : a prospective cohort study

Bruno Ledergerber;Matthias Egger;Milos Opravil;Amalio Telenti.
The Lancet (1999)

1096 Citations

Response to antiretroviral treatment in HIV-1-infected individuals with allelic variants of the multidrug resistance transporter 1: a pharmacogenetics study.

Jacques Fellay;Catia Marzolini;Emma R. Meaden;David J. Back.
The Lancet (2002)

793 Citations

Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis.

Monika Müller;Simon Wandel;Robert Colebunders;Suzanna Attia.
Lancet Infectious Diseases (2010)

708 Citations

AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study.

Bruno Ledergerber;M. Egger;V. Erard;R. Weber.
JAMA (1999)

630 Citations

Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study

Barbara Hasse;Bruno Ledergerber;Hansjakob Furrer;Manuel Battegay.
Clinical Infectious Diseases (2011)

625 Citations

Mycobacterium avium subspecies paratuberculosis and Crohn's disease: a systematic review and meta-analysis.

Martin Feller;Karin Huwiler;Roger Stephan;Ekkehardt Altpeter.
Lancet Infectious Diseases (2007)

581 Citations

CD4 T-Lymphocyte Recovery in Individuals With Advanced HIV-1 Infection Receiving Potent Antiretroviral Therapy for 4 Years: The Swiss HIV Cohort Study

Gilbert R. Kaufmann;Luc Perrin;Guiseppe Pantaleo;Milos Opravil.
JAMA Internal Medicine (2003)

498 Citations

Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study

Jacques Fellay;Bruno Ledergerber;Enos Bernasconi;Hansjakob Furrer.
The Lancet (2001)

461 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Hansjakob Furrer

Huldrych F. Günthard

Huldrych F. Günthard

University of Zurich

Publications: 181

Manuel Battegay

Manuel Battegay

University Hospital of Basel

Publications: 173

Jens D. Lundgren

Jens D. Lundgren

Rigshospitalet

Publications: 170

Caroline Sabin

Caroline Sabin

University College London

Publications: 157

Matthias Cavassini

Matthias Cavassini

University of Lausanne

Publications: 152

Andrew N. Phillips

Andrew N. Phillips

University College London

Publications: 151

Matthias Egger

Matthias Egger

University of Bern

Publications: 132

Julio S. G. Montaner

Julio S. G. Montaner

University of British Columbia

Publications: 132

Peter Reiss

Peter Reiss

University of Amsterdam

Publications: 125

Robert S. Hogg

Robert S. Hogg

Simon Fraser University

Publications: 123

Dominique Costagliola

Dominique Costagliola

Université Paris Cité

Publications: 117

Enos Bernasconi

Enos Bernasconi

Universita della Svizzera Italiana

Publications: 111

Bruno Ledergerber

Bruno Ledergerber

University of Zurich

Publications: 108

Amanda Mocroft

Amanda Mocroft

University College London

Publications: 107

Antonella d'Arminio Monforte

Antonella d'Arminio Monforte

University of Milan

Publications: 105

Rainer Weber

Rainer Weber

University of Zurich

Publications: 95

Something went wrong. Please try again later.